During the past decade, Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore" #1 collaborator was "Study Alliance Leukemia (SAL) Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore" are "Acute Myeloid Leukemia" (2 trials), "Chronic Myeloid Leukemia" (2 trials), "Leukemia" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials) and "Philadelphia-Positive ALL" (2 trials). Many other conditions were trialed in "Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore" in a lesser frequency.

Most popular intervention types in "Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore" are "Drug" (13 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nilotinib" (3 trials), "Imatinib" (2 trials), "all-trans retinoic acid (ATRA)" (2 trials), "rituximab [MabThera/Rituxan]" (2 trials) and "Allogeneic SCT or Autologous SCT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".